90Y and 111In Complexes of a DOTA-Conjugated Integrin αvβ3 Receptor Antagonist: Different but Biologically Equivalent

MLA

D. Scott Edwards, et al. “90Y and 111In Complexes of a DOTA-Conjugated Integrin Αvβ3 Receptor Antagonist: Different but Biologically Equivalent.” Bioconjugate Chemistry, vol. 15, Feb. 2004, pp. 235–41. EBSCOhost, https://doi.org/10.1021/bc034108q.

APA

D. Scott Edwards, John A. Barrett, David C. Onthank, Thomas D. Harris, Simon P. Robinson, Paula Silva, & Shuang Liu. (2004). 90Y and 111In Complexes of a DOTA-Conjugated Integrin αvβ3 Receptor Antagonist: Different but Biologically Equivalent. Bioconjugate Chemistry, 15, 235–241. https://doi.org/10.1021/bc034108q

Chicago

D. Scott Edwards, John A. Barrett, David C. Onthank, Thomas D. Harris, Simon P. Robinson, Paula Silva, and Shuang Liu. 2004. “90Y and 111In Complexes of a DOTA-Conjugated Integrin Αvβ3 Receptor Antagonist: Different but Biologically Equivalent.” Bioconjugate Chemistry 15 (February): 235–41. doi:10.1021/bc034108q.